Carl Plager
Impact in
- Oncology top 1%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
- Ophthalmology top 1%
- Ocular Oncology and Treatments
Papers in
- Oncology 32
- Cutaneous Melanoma Detection and Management 7
- Cancer Immunotherapy and Biomarkers 6
-
- Sarcoma Diagnosis and Treatment 17
- Co-authors
- Robert S. Benjamin (41 shared papers)Omar E. Eton (18 shared papers)Agop Y. Bedikian (16 shared papers)Sewa S. Legha (20 shared papers)Sigrid E. Ring (13 shared papers)SHREYASKUMAR R. PATEL (15 shared papers)Nicholas E. Papadopoulos (22 shared papers)Antonio Carlos Buzaid (11 shared papers)
- Journals
- Cancer (15 papers)Journal of Clinical Oncology (13 papers)Melanoma Research (9 papers)Annals of Oncology (2 papers)Anti-Cancer Drugs (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Carl Plager
71 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 101
- Oncology 2.1k
- Ophthalmology 355
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 728
- Gastroenterology 96
Countries citing papers authored by Carl Plager
This map shows the geographic impact of Carl Plager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Plager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Plager more than expected).
Fields of papers citing papers by Carl Plager
This network shows the impact of papers produced by Carl Plager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Plager. The network helps show where Carl Plager may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl Plager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 300 | |
| 2 | 1995 | 275 | |
| 3 | 1997 | 245 | |
| 4 | 1998 | 243 | |
| 5 | 2001 | 212 | |
| 6 | 1997 | 207 | |
| 7 | 1998 | 181 | |
| 8 | 1998 | 163 | |
| 9 | Osteosarcoma chemotherapy effect: a prognostic factor. | 1987 | 153 |
| 10 | 1989 | 150 | |
| 11 | 1996 | 145 | |
| 12 | 1989 | 116 | |
| 13 | 2002 | 98 | |
| 14 | 1994 | 96 | |
| 15 | 1989 | 82 | |
| 16 | 2001 | 79 | |
| 17 | 2000 | 76 | |
| 18 | 1998 | 67 | |
| 19 | 1996 | 63 | |
| 20 | 2003 | 63 |
About Carl Plager
Carl Plager is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 71 papers that have together received 4.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (17 papers), Immunotherapy and Immune Responses (9 papers), Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Multiple Myeloma Research and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Oncology (2.1k citations), Ophthalmology (355 citations), Pulmonary and Respiratory Medicine (1.1k citations), Immunology (728 citations) and Gastroenterology (96 citations). Carl Plager has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert S. Benjamin, Omar E. Eton, Agop Y. Bedikian, Sewa S. Legha, Sigrid E. Ring, SHREYASKUMAR R. PATEL, Nicholas E. Papadopoulos, Antonio Carlos Buzaid, Nicholas Papadopolous and M. A. Burgess. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Melanoma Research, Annals of Oncology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.